The LAM Treatment Alliance ("LTA") is a 501(c)(3) non-profit organization dedicated to fostering research and patient partnerships in order to find a treatment for LAM (lymphangioleiomyomatosis) in the fastest time possible. LAM is a rare and fatal disease that affects women in their childbearing years. LAM is fatal as thin-walled cysts progressively destroy healthy lung tissue. It causes shortness of breath and suffocates its victims to death as the disease progresses. There is no effective treatment. The LAM Treatment Alliance mobilizes expertise, eliminates barriers to treatment research, funds and fast tracks core research and supports patient links to clinicians, other patients and researchers. Each year, this progressive multi-system disease, fatal in the lungs, strikes hundreds of thousands of women across the globe. Since its inception, the LAM Treatment Alliance has grown to become a critical convener for the field, forging strategic collaborations with academia, the pharmaceutical industry, government agencies and other private individual, community / corporate supporters. This fast paced, entrepreneurial environment commands high energy, highest standards for performance, proactive problem-solving abilities, and a service-driven can-do attitude.
To apply for positions at the LAM Treatment Alliance (LTA), please provide the following via Email: firstname.lastname@example.org
Alternatively, you can mail documents to us at our mailing address:
LAM Treatment Alliance
64 Church Street, 2nd Floor
Cambridge, MA 02138